NCT05409833

Brief Summary

Systemic transthyretin amyloidosis is an aging-related disorder. It is usually associated with cardiac disease but also extends to other organs. Recent studies found that idiopathic carpal tunnel syndrome patients may have amyloid deposition in tenosynovial tissue. The main aims of this project are the characterization of the association between idiopathic carpal tunnel syndrome and transthyretin amyloidosis and its evaluation as a predictive factor of cardiac amyloidosis

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2020

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

June 3, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

June 8, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

October 19, 2023

Status Verified

June 1, 2023

Enrollment Period

4 years

First QC Date

June 3, 2022

Last Update Submit

October 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Frequency of transthyretin amyloidosis in synovial in patients with ≥60 years old

    Number of patients with transthyretin amyloidosis in synovial in relation to total number of patients submitted to hand surgery

    24 months

Secondary Outcomes (2)

  • Association between synovial transthyretin amyloidosis with carpal tunnel syndrome

    24 months

  • Association between idiopathic carpal tunnel syndrome with cardiac transthyretin amyloidosis

    24 months

Study Arms (2)

Group 1

Patients aged ≥ 60 years old with symptomatic carpal tunnel syndrome submitted to surgery

Diagnostic Test: Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD

Group 2

Patients aged ≥ 60 years old without symptomatic carpal tunnel syndrome submitted to hand surgery

Diagnostic Test: Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD

Interventions

Congo red and Immunohistochemical analysis and/or Mass spectrometry analysis

Group 1Group 2

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with ≥60 years old submitted to hand surgery

You may qualify if:

  • Patients aged ≥ 60 years old with symptomatic idiopathic carpal tunnel syndrome or other hand surgery indications.

You may not qualify if:

  • Diabetes mellitus, hypothyroidism, hemodialysis, rheumatoid arthritis, and other inflammatory arthropathies, multiple myeloma, gout, chondrocalcinosis, Colles fracture, space-occupying lesions, and infectious synovitis.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centro Hospitalar Universitário São João

Porto, 4200-319, Portugal

RECRUITING

Faculty of Medicine (FMUP)

Porto, 4200-319, Portugal

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

biopsy and peripheral blood

MeSH Terms

Conditions

Amyloidosis, Hereditary, Transthyretin-RelatedCarpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Elisabete Martins, MD, PhD

    Universidade do Porto

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Elisabete Martins, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 3, 2022

First Posted

June 8, 2022

Study Start

June 1, 2020

Primary Completion

June 1, 2024

Study Completion

June 1, 2025

Last Updated

October 19, 2023

Record last verified: 2023-06

Locations